203 related articles for article (PubMed ID: 36172817)
1. Plasminogen activator-coated nanobubbles targeting cellbound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategy.
Macor P; Durigutto P; Argenziano M; Smith-Jackson K; Capolla S; Di Leonardo V; Marchbank K; Tolva VS; Semeraro F; Ammollo CT; Colucci M; Cavalli R; Meroni P; Tedesco F
Haematologica; 2023 Jul; 108(7):1861-1872. PubMed ID: 36172817
[TBL] [Abstract][Full Text] [Related]
2. The mouse dorsal skinfold chamber as a model for the study of thrombolysis by intravital microscopy.
Boulaftali Y; Lamrani L; Rouzaud MC; Loyau S; Jandrot-Perrus M; Bouton MC; Ho-Tin-Noé B
Thromb Haemost; 2012 May; 107(5):962-71. PubMed ID: 22552380
[TBL] [Abstract][Full Text] [Related]
3. Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy.
Chen HA; Ma YH; Hsu TY; Chen JP
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32294917
[TBL] [Abstract][Full Text] [Related]
4. Potent Thrombolytic Effect of
Martinez de Lizarrondo S; Gakuba C; Herbig BA; Repessé Y; Ali C; Denis CV; Lenting PJ; Touzé E; Diamond SL; Vivien D; Gauberti M
Circulation; 2017 Aug; 136(7):646-660. PubMed ID: 28487393
[TBL] [Abstract][Full Text] [Related]
5. beta2-glycoprotein i is a cofactor for tissue plasminogen activator-mediated plasminogen activation.
Bu C; Gao L; Xie W; Zhang J; He Y; Cai G; McCrae KR
Arthritis Rheum; 2009 Feb; 60(2):559-68. PubMed ID: 19180513
[TBL] [Abstract][Full Text] [Related]
6. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.
Mruk JS; Zoldhelyi P; Webster MW; Heras M; Grill DE; Holmes DR; Fuster V; Chesebro JH
Circulation; 1996 Feb; 93(4):792-9. PubMed ID: 8641009
[TBL] [Abstract][Full Text] [Related]
7. Value of isolated IgA anti-β2 -glycoprotein I positivity in the diagnosis of the antiphospholipid syndrome.
Murthy V; Willis R; Romay-Penabad Z; Ruiz-Limón P; Martínez-Martínez LA; Jatwani S; Jajoria P; Seif A; Alarcón GS; Papalardo E; Liu J; Vilá LM; McGwin G; McNearney TA; Maganti R; Sunkureddi P; Parekh T; Tarantino M; Akhter E; Fang H; Gonzalez EB; Binder WR; Norman GL; Shums Z; Teodorescu M; Reveille JD; Petri M; Pierangeli SS
Arthritis Rheum; 2013 Dec; 65(12):3186-93. PubMed ID: 23983008
[TBL] [Abstract][Full Text] [Related]
8. Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I.
Ioannou Y; Zhang JY; Qi M; Gao L; Qi JC; Yu DM; Lau H; Sturgess AD; Vlachoyiannopoulos PG; Moutsopoulos HM; Rahman A; Pericleous C; Atsumi T; Koike T; Heritier S; Giannakopoulos B; Krilis SA
Arthritis Rheum; 2011 Sep; 63(9):2774-82. PubMed ID: 21618459
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Tissue Plasminogen Activator-conjugated Nanoparticles Effectively Targets Thrombolysis in a Rat Model of Middle Cerebral Artery Occlusion.
Deng J; Mei H; Shi W; Pang ZQ; Zhang B; Guo T; Wang HF; Jiang XG; Hu Y
Curr Med Sci; 2018 Jun; 38(3):427-435. PubMed ID: 30074208
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Plasminogen Activator Modified Nanoparticles for Targeting Thrombolysis in Branch Retinal Vein Occlusion.
Zhang H; Han S; Zhang L; Guo Y; Li Y
Cell Mol Biol (Noisy-le-grand); 2022 Mar; 68(3):201-212. PubMed ID: 35988180
[TBL] [Abstract][Full Text] [Related]
11. A Fibrinogen-Mimicking, Activated-Platelet-Sensitive Nanocoacervate Enhances Thrombus Targeting and Penetration of Tissue Plasminogen Activator for Effective Thrombolytic Therapy.
Huang Y; Jiang J; Ren J; Guo Y; Zhao Q; Zhou J; Li Y; Chen R
Adv Healthc Mater; 2022 Oct; 11(19):e2201265. PubMed ID: 35864062
[TBL] [Abstract][Full Text] [Related]
12. Polyacrylic acid-coated nanoparticles loaded with recombinant tissue plasminogen activator for the treatment of mice with ischemic stroke.
Huang L; Wang J; Huang S; Siaw-Debrah F; Nyanzu M; Zhuge Q
Biochem Biophys Res Commun; 2019 Aug; 516(2):565-570. PubMed ID: 31235258
[TBL] [Abstract][Full Text] [Related]
13. Development of a carotid artery thrombolysis stroke model in mice.
Maclean JAA; Tomkins AJ; Sturgeon SA; Hofma BR; Alwis I; Samson AL; Schoenwaelder SM; Jackson SP
Blood Adv; 2022 Sep; 6(18):5449-5462. PubMed ID: 35767737
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic effects of thrombolytic agents in a platelet-rich femoral vein thrombosis model in the hamster.
Stassen JM; Nyström A; Hoylaerts M; Collen D
Circulation; 1995 Mar; 91(5):1330-5. PubMed ID: 7867170
[TBL] [Abstract][Full Text] [Related]
15. Tolerogenic β2-glycoprotein I DNA vaccine and FK506 as an adjuvant attenuates experimental obstetric antiphospholipid syndrome.
Chao YH; Chen DY; Lan JL; Tang KT; Lin CC
PLoS One; 2018; 13(6):e0198821. PubMed ID: 29894515
[TBL] [Abstract][Full Text] [Related]
16. The putative mechanism of thrombosis in antiphospholipid syndrome: impairment of the protein C and the fibrinolytic systems by monoclonal anticardiolipin antibodies.
Ieko M; Sawada KI; Koike T; Notoya A; Mukai M; Kohno M; Wada N; Itoh T; Yoshioka N
Semin Thromb Hemost; 1999; 25(5):503-7. PubMed ID: 10625210
[TBL] [Abstract][Full Text] [Related]
17. The use of the Chandler loop to examine the interaction potential of NXY-059 on the thrombolytic properties of rtPA on human thrombi in vitro.
Mutch NJ; Moore NR; Mattsson C; Jonasson H; Green AR; Booth NA
Br J Pharmacol; 2008 Jan; 153(1):124-31. PubMed ID: 17982476
[TBL] [Abstract][Full Text] [Related]
18. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Cerebroprotection of Xenon-Loaded Liposomes in Combination with rtPA Thrombolysis for Embolic Ischemic Stroke.
Peng T; Booher K; Moody MR; Yin X; Aronowski J; McPherson DD; Savitz SI; Kim H; Huang SL
Biomolecules; 2023 Aug; 13(8):. PubMed ID: 37627321
[TBL] [Abstract][Full Text] [Related]
20. Carbamylation of β2-glycoprotein I generates new autoantigens for antiphospholipid syndrome: a new tool for diagnosis of 'seronegative' patients.
Capozzi A; Truglia S; Buttari B; Recalchi S; Riitano G; Manganelli V; Mancuso S; Alessandri C; Longo A; Mattei V; Profumo E; Garofalo T; Misasi R; Conti F; Sorice M
Rheumatology (Oxford); 2022 Oct; 61(10):4187-4197. PubMed ID: 35108369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
